A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
A phase I randomised, double-blind, placebo-controlled study of single and repeated ascending
doses in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of
inhaled chf 6001.